3 rezultatima
OBJECTIVE
To explore the anti-viral mechanism of kurarinol through studying its influence on cytotoxic T lymphocyte (CTL) surface program death receptor-1 (PD-1) expression of patients with chronic hepatitis B (CHB).
METHODS
69 cases of CHB, HBV DNA > or = 10(4) copies/ml, HBeAg positive, human
OBJECTIVE
To explore effects of kurarinol combined with Diammonium Glycyrrhizinate on specific cellular immunity of patients with chronic hepatitis B (CHB).
METHODS
Sixty-three CHB patients were randomly divided into two groups, 32 cases in group of kurarinol combined with Diammonium Glycyrrhizinate
OBJECTIVE
To explore influence of Kurarinol on specific and non-specific cell immunity in patients with chronic hepatitis B.
METHODS
74 cases of CHB were randomly divided into two groups, 36 cases in treatment group, treated with 600 mg Kurarinol glucose injection, IV, once a day. After one month,